Medicenna Says MDNA209 Extends Survival Up to Fourfold in Mouse Models
The company reported that MDNA209 extended median survival up to fourfold in mouse models of acute graft-versus-host disease.
The company reported that MDNA209 extended median survival up to fourfold in mouse models of acute graft-versus-host disease.